Literature DB >> 19803557

Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals.

Josh J Carlson1, Louis P Garrison, Sean D Sullivan.   

Abstract

Mesh：

Year:  2009        PMID： 19803557     DOI： 10.18553/jmcp.2009.15.8.683

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN： 1083-4087


× No keyword cloud information.
  9 in total

Review 1.  Market access of cancer drugs in European countries: improving resource allocation.

Authors:  Kim Pauwels; Isabelle Huys; Minne Casteels; Katelijne De Nys; Steven Simoens
Journal:  Target Oncol       Date:  2013-11-19       Impact factor: 4.493

2.  Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.

Authors:  Adrian Towse; Louis P Garrison
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 3.  Cost, coverage, and comparative effectiveness research: the critical issues for oncology.

Authors:  Steven D Pearson
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

4.  Valorising and creating access to innovative medicines in the European union.

Authors:  Lieven Annemans; Irina Cleemput; Frank Hulstaert; Steven Simoens
Journal:  Front Pharmacol       Date:  2011-10-11       Impact factor: 5.810

5.  Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future.

Authors:  Kim Pauwels; Isabelle Huys; Sabine Vogler; Minne Casteels; Steven Simoens
Journal:  Front Pharmacol       Date:  2017-04-04       Impact factor: 5.810

Review 6.  Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends.

Authors:  Trevor Jozef Piatkiewicz; Janine Marie Traulsen; Tove Holm-Larsen
Journal:  Pharmacoecon Open       Date:  2018-06

Review 7.  Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.

Authors:  Gregory P Hess; Eileen Fonseca; Rachel Scott; Jesen Fagerness
Journal:  Genet Res (Camb)       Date:  2015-06-01       Impact factor: 1.588

Review 8.  Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care.

Authors:  Brandon Swift; Lokesh Jain; Craig White; Vasu Chandrasekaran; Aman Bhandari; Dyfrig A Hughes; Pravin R Jadhav
Journal:  Clin Transl Sci       Date:  2018-05-16       Impact factor: 4.689

9.  Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making.

Authors:  Robbe Saesen; Stéphane Lejeune; Gianluca Quaglio; Denis Lacombe; Isabelle Huys
Journal:  Front Pharmacol       Date:  2020-02-05       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.